September 29, 2016 4:10 PM ET

Capital Markets

Company Overview of PathoCapital

Executive Profile

Wilbur H. Gantz III, MBA,BA

Chief Executive Officer and President, PathoCapital
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 11 different industries.

See Board Relationships
78--

Background

Mr. Wilbur H. Gantz, III, MBA,BA also known as Bill, serves as the Chief Executive Officer and President of PathoCapital LLC. Mr. Gantz serves as a Member of Advisory Board and Senior Advisor at Paragon Pharmaceuticals LLC. He is a Partner of Adam Street Partners, LLP. He served as the Chief Executive Officer and Chairman of Lundbeck Inc. since September 2002. Prior to joining Ovation, Mr. Gantz served as the Chief Executive Officer and President of PathoGenesis Corporation ...

Corporate Headquarters

--
--, -- --

United States

Phone: --
Fax: --

Board Members Memberships

Director
Director
Director
Executive Chairman
Director
2011-Present
Executive Chairman
2013-Present
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

MBA
Harvard Business School
BA
Princeton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PathoCapital, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.